A Los Angeles-based biotechnology company, ImmunoCellular Therapeutics (IMUC), has developed a vaccine against glioblastoma (brain cancer) stem cells. This vaccine targets a specific "tag" that is found on the surface of glioblastoma, multiple myeloma, and several other types of cancer stem cells (CSCs), making multiple myeloma a potential target for the vaccine.

CSCs continually renew themselves and have the ability to give rise to all cell types found in a particular cancer, causing tumors to …

Patient Advocate Foundation Co-pay Relief Program - The Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) provides financial help to insured patients with multiple myeloma and other cancers who qualify for co-payment assistance. Participants can also receive personal, over-the-phone assistance from counselors to help them with the sign-up process. To learn more, visit the PAF CPR site.

Hi-Rex Studios and the Leukemia & Lymphoma Society Team Up for Video Game Charity Event - Hi-Rez Studios, …